Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner

Journal of Biological Chemistry

Volumn 287, Issue 21, 2012, Pages 17248-17256

  Zhou, Jian ^a   Qin, Li ^a   Tien, Jean Ching Yi ^a,b   Gao, Li ^a   Chen, Xian ^a,b   Wang, Fen ^b   Hsieh, Jer Tsong ^c,d   Xu, Jianming ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONSERVED PROTEINS; EPITHELIAL CELLS; GROWTH INHIBITION; HOMEOPROTEINS; POINT MUTATIONS; PROSTATE CANCERS; REGULATORY SEQUENCES; TARGET GENES; TUMOR SUPPRESSORS;

BODY FLUIDS; CELL PROLIFERATION; CELLS; DIAGNOSIS; GENES; TRANSCRIPTION FACTORS; UROLOGY;

CELL CULTURE;

ALANINE; BIOLOGICAL MARKER; THREONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MUTATION, MISSENSE; PARACRINE COMMUNICATION; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 84861215653     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.336909     Document Type: Article

References (32)

1. Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R., Abate- Shen, C., and Shen, M. M. (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 13, 966-977 (Pubitemid 29200980)
2. Tanaka, M., Lyons, G. E., and Izumo, S. (1999) Expression of the Nkx3.1 homobox gene during pre- and postnatal development. Mech. Dev. 85, 179-182 (Pubitemid 29343762)
3. Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. (1994) Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res. 54, 3273-3277 (Pubitemid 24208941)
4. Emmert-Buck, M. R., Vocke, C. D., Pozzatti, R. O., Duray, P. H., Jennings, S. B., Florence, C. D., Zhuang, Z., Bostwick, D. G., Liotta, L. A., and Linehan, W. M. (1995) Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res. 55, 2959-2962
5. Vocke, C. D., Pozzatti, R. O., Bostwick, D. G., Florence, C. D., Jennings, S. B., Strup, S. E., Duray, P. H., Liotta, L. A., Emmert-Buck, M. R., and Linehan, W. M. (1996) Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res. 56, 2411-2416 (Pubitemid 26154091)
6. Häggman, M. J., Wojno, K. J., Pearsall, C. P., and Macoska, J. A. (1997) Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology 50, 643-647 (Pubitemid 27433235)
7. Swalwell, J. I., Vocke, C. D., Yang, Y., Walker, J. R., Grouse, L., Myers, S. H., Gillespie, J. W., Bostwick, D. G., Duray, P. H., Linehan, W. M., and Emmert- Buck, M. R. (2002) Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer. Genes Chromosomes Cancer 33, 201-205 (Pubitemid 34052501)
8. Eeles, R. A., Kote-Jarai, Z., Al Olama, A. A., Giles, G. G., Guy, M., Severi, G., Muir, K., Hopper, J. L., Henderson, B. E., Haiman, C. A., Schleutker, J., Hamdy, F. C., Neal, D. E., Donovan, J. L., Stanford, J. L., Ostrander, E. A., Ingles, S. A., John, E. M., Thibodeau, S. N., Schaid, D., Park, J. Y., Spurdle, A., Clements, J., Dickinson, J. L., Maier, C., Vogel, W., Dork, T., Rebbeck, T. R., Cooney, K. A., Cannon-Albright, L., Chappuis, P. O., Hutter, P., Zeegers, M., Kaneva, R., Zhang, H. W., Lu, Y. J., Foulkes, W. D., English, D. R., Leongamornlert, D. A., Tymrakiewicz, M., Morrison, J., Ardern- Jones, A. T., Hall, A. L., O'Brien, L. T., Wilkinson, R. A., Saunders, E. J., Page, E. C., Sawyer, E. J., Edwards, S. M., Dearnaley, D. P., Horwich, A., Huddart, R. A., Khoo, V. S., Parker, C. C., Van As, N., Woodhouse, C. J., Thompson, A., Christmas, T., Ogden, C., Cooper, C. S., Southey, M. C., Lophatananon, A., Liu, J. F., Kolonel, L. N., Le Marchand, L., Wahlfors, T., Tammela, T. L., Auvinen, A., Lewis, S. J., Cox, A., FitzGerald, L. M., Koopmeiners, J. S., Karyadi, D. M., Kwon, E. M., Stern, M. C., Corral, R., Joshi, A. D., Shahabi, A., McDonnell, S. K., Sellers, T. A., Pow-Sang, J., Chambers, S., Aitken, J., Gardiner, R. A., Batra, J., Kedda, M. A., Lose, F., Polanowski, A., Patterson, B., Serth, J., Meyer, A., Luedeke, M., Stefflova, K., Ray, A. M., Lange, E. M., Farnham, J., Khan, H., Slavov, C., Mitkova, A., Cao, G., and Easton, D. F. (2009) Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet. 41, 1116-1121
9. Akamatsu, S., Takata, R., Ashikawa, K., Hosono, N., Kamatani, N., Fujioka, T., Ogawa, O., Kubo, M., Nakamura, Y., and Nakagawa, H. (2010) A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression. Hum. Mol. Genet 19, 4265-4272
10. Kim, M. J., Bhatia-Gaur, R., Banach-Petrosky, W. A., Desai, N., Wang, Y., Hayward, S. W., Cunha, G. R., Cardiff, R. D., Shen, M. M., and Abate-Shen, C. (2002) Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res. 62, 2999-3004 (Pubitemid 34602384)
11. Abdulkadir, S. A., Magee, J. A., Peters, T. J., Kaleem, Z., Naughton, C. K., Humphrey, P. A., and Milbrandt, J. (2002) Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol. Cell. Biol. 22, 1495-1503 (Pubitemid 34150785)
12. Shen, M. M., and Abate-Shen, C. (2003) Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev. Dyn. 228, 767-778 (Pubitemid 37493996)
13. Voeller, H. J., Augustus, M., Madike, V., Bova, G. S., Carter, K. C., and Gelmann, E. P. (1997) Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res. 57, 4455-4459 (Pubitemid 27441043)
14. Ornstein, D. K., Cinquanta, M., Weiler, S., Duray, P. H., Emmert-Buck, M. R., Vocke, C. D., Linehan, W. M., and Ferretti, J. A. (2001) Expression studies and mutational analysis of the androgen-regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium. J. Urol. 165, 1329-1334 (Pubitemid 32210285)
15. Xu, L. L., Srikantan, V., Sesterhenn, I. A., Augustus, M., Dean, R., Moul, J. W., Carter, K. C., and Srivastava, S. (2000) Expression profile of an androgen-regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. J. Urol. 163, 972-979 (Pubitemid 30091673)
16. Bowen, C., Bubendorf, L., Voeller, H. J., Slack, R., Willi, N., Sauter, G., Gasser, T. C., Koivisto, P., Lack, E. E., Kononen, J., Kallioniemi, O. P., and Gelmann, E. P. (2000) Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res. 60, 6111-6115
17. Gelmann, E. P., Bowen, C., and Bubendorf, L. (2003) Expression of NKX3.1 in normal and malignant tissues. Prostate 55, 111-117 (Pubitemid 36443998)
18. Korkmaz, C. G., Korkmaz, K. S., Manola, J., Xi, Z., Risberg, B., Danielsen, H., Kung, J., Sellers, W. R., Loda, M., and Saatcioglu, F. (2004) Analysis of androgen-regulated homeobox gene NKX3.1 during prostate carcinogenesis. J. Urol. 172, 1134-1139 (Pubitemid 39096487)
19. Bethel, C. R., Faith, D., Li, X., Guan, B., Hicks, J. L., Lan, F., Jenkins, R. B., Bieberich, C. J., and De Marzo, A. M. (2006) Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: Association with Gleason score and chromosome 8p deletion. Cancer Res. 66, 10683-10690 (Pubitemid 44876963)
20. Aslan, G., Irer, B., Tuna, B., Yorukoglu, K., Saatcioglu, F., and Celebi, I. (2006) Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Pathol. Res. Pract. 202, 93-98 (Pubitemid 43125709)
21. Tanaka, M., Komuro, I., Inagaki, H., Jenkins, N. A., Copeland, N. G., and Izumo, S. (2000) Nkx3.1, a murine homolog of Drosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands. Dev. Dyn. 219, 248-260
22. Magee, J. A., Abdulkadir, S. A., and Milbrandt, J. (2003) Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 3, 273-283 (Pubitemid 37443882)
23. Lei, Q., Jiao, J., Xin, L., Chang, C. J., Wang, S., Gao, J., Gleave, M. E., Witte, O. N., Liu, X., and Wu, H. (2006) NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 9, 367-378 (Pubitemid 43668733)
24. Zhoul, J., Hernandez, G., Tu, S. W., Huang, C. L., Tseng, C. P., and Hsieh, J. T. (2005) The role of DOC-2/DAB2 in modulating androgen receptormediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. Cancer Res. 65, 9906-9913 (Pubitemid 41541471)
25. Qin, L., Chen, X., Wu, Y., Feng, Z., He, T., Wang, L., Liao, L., and Xu, J. (2011) Steroid receptor coactivator-1 up-regulates integrin α5 expression to promote breast cancer cell adhesion and migration. Cancer Res. 71, 1742-1751
26. Song, H., Zhang, B., Watson, M. A., Humphrey, P. A., Lim, H., and Milbrandt, J. (2009) Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene 28, 3307-3319
27. Chung, A. C., Zhou, S., Liao, L., Tien, J. C., Greenberg, N. M., and Xu, J. (2007) Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice. Cancer Res. 67, 5965-5975 (Pubitemid 46985033)
28. Economides, K. D., and Capecchi, M. R. (2003) Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130, 2061-2069 (Pubitemid 36656703)
29. Zheng, S. L., Ju, J. H., Chang, B. L., Ortner, E., Sun, J., Isaacs, S. D., Sun, J., Wiley, K. E., Liu, W., Zemedkun, M., Walsh, P. C., Ferretti, J., Gruschus, J., Isaacs, W. B., Gelmann, E. P., and Xu, J. (2006) Germ line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res. 66, 69-77 (Pubitemid 43166011)
30. Dupont, E., Prochiantz, A., and Joliot, A. (2007) Identification of a signal peptide for unconventional secretion. J. Biol. Chem. 282, 8994-9000 (Pubitemid 47093538)
31. Zhou, J., Liu, W., Pong, R. C., Hao, G., Sun, X., and Hsieh, J. T. (2012) Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells. Amino Acids 42, 1253-1260
32. Holland, P. W., Booth, H. A., and Bruford, E. A. (2007) Classification and nomenclature of all human homeobox genes. BMC Biol. 5, 47